Back to top

earnings: Archive

Zacks Equity Research

Match Group (MTCH) Q1 Earnings Beat Estimates, Revenues Up Y/Y

Match Group's (MTCH) first-quarter results benefit from strength in Tinder and Hinge despite sluggish growth in total payers.

AMZNNegative Net Change TGTPositive Net Change GPSPositive Net Change MTCHNegative Net Change

Zacks Equity Research

Mr. Cooper (COOP) Rises 3% Since Q1 Earnings Beat: Growth Ahead?

For the second quarter, Mr. Cooper (COOP) expects Originations pretax income to be in the $30-$40 million range.

DFSPositive Net Change ALLYNegative Net Change VIRTPositive Net Change COOPPositive Net Change

Zacks Equity Research

Will Healthy Revenue Growth Boost Akamai's (AKAM) Q1 Earnings?

Akamai (AKAM) is expected to report a top-line expansion year over year, backed by healthy demand trends in several verticals.

NVDANegative Net Change AKAMPositive Net Change CCOIPositive Net Change SONYNegative Net Change

Zacks Equity Research

Brighthouse (BHF) Q1 Earnings Beat, Revenues Miss Estimates

Brighthouse Financial (BHF) first-quarter results reflect higher premiums and net investment income as well as lower expenses.

LNCNegative Net Change RGAPositive Net Change VOYANegative Net Change BHFNegative Net Change

Zacks Equity Research

Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates

Intra-Cellular (ITCI) reports first-quarter 2024 results, wherein both earnings and revenues beat estimates, driven by strong Caplyta sales.

LGNDPositive Net Change ANIPNegative Net Change ITCINegative Net Change ANVSNegative Net Change

Zacks Equity Research

iRobot (IRBT) Incurs Narrower-Than-Expected Net Loss in Q1

iRobot (IRBT) first-quarter 2024 revenues decline 6.4% on account of lower sales of solo and other products.

RBCPositive Net Change IRBTPositive Net Change CRNegative Net Change LXFRPositive Net Change

Zacks Equity Research

Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues

Pacira (PCRX) reports first-quarter 2024 results, wherein earnings miss but revenues beat estimates, driven by Exparel sales.

LGNDPositive Net Change PCRXPositive Net Change ANIPNegative Net Change ANVSNegative Net Change

Zacks Equity Research

Fidelity National's (FIS) Shares Up 5.5% Since Q1 Earnings Beat

Fidelity National (FIS) revises its adjusted EPS guidance between $4.88 and $4.98, the mid-point of which implies a 46.3% surge from the 2023 figure of $3.37.

MANegative Net Change FISNegative Net Change WUNegative Net Change GPNPositive Net Change

Zacks Equity Research

Inspire Medical (INSP) Q1 Earnings Beat, Gross Margin Up

Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.

BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change INSPNegative Net Change

Zacks Equity Research

Masimo (MASI) Q1 Earnings Beat Estimates, '24 EPS View Up

Masimo's (MASI) Q1 healthcare revenues reflect strong sensor orders, which were completely offset by lower capital equipment purchases. Sensor production in Malaysia is likely to improve Healthcare gross margin.

BSXNegative Net Change ECLPositive Net Change ALGNNegative Net Change MASINegative Net Change

Zacks Equity Research

Electronic Arts (EA) Q4 Earnings and Revenues Decline Y/Y

Electronic Arts' (EA) fourth-quarter fiscal 2024 results reflect softness in demand for live services and full-game revenues.

TTWONegative Net Change EANegative Net Change SNNegative Net Change RBLXNegative Net Change

Zacks Equity Research

Pediatrix (MD) Q1 Earnings Beat on Hospital Contract Fees

Pediatrix's (MD) Q1 results benefit from higher same-unit revenues, resulting from growing patient volumes, partly offset by high costs. It continues to expect 2024 adjusted EBITDA within $200-$220 million.

MOHNegative Net Change MDNegative Net Change CNCPositive Net Change ENSGNegative Net Change

Zacks Equity Research

Fresenius Medical (FMS) Q1 Earnings Beat, Operating Margin Up

Fresenius Medical's (FMS) first-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income.

BSXNegative Net Change ECLPositive Net Change ALGNNegative Net Change FMSPositive Net Change

Zacks Equity Research

PRA Group's (PRAA) Shares Down Despite Q1 Earnings Beat

PRA Group's (PRAA) first-quarter results benefit from improved collections from Brazil, Europe and the United States. Rising legal collection costs and fees partially offset the results.

PRAAPositive Net Change CBOEPositive Net Change EEFTPositive Net Change VIRTPositive Net Change

Zacks Equity Research

American Public (APEI) Stock Dips Despite Q1 Earnings Beat

American Public's (APEI) first-quarter results reflect strong performance and enrollment across its segments, barring GSUSA and RU performance.

APEIPositive Net Change STRAPositive Net Change LEGNegative Net Change ATGEPositive Net Change

Zacks Equity Research

Autoliv (ALV) Stock Up 7% Since Q1 Earnings & Sales Beat

Autoliv (ALV) forecasts full-year 2024 organic sales growth and adjusted operating margin to be around 5% and 10.5%, respectively.

ALVPositive Net Change BWAPositive Net Change OSKPositive Net Change GNTXNegative Net Change

Zacks Equity Research

Quaker Chemical's (KWR) Q1 Earnings Beat Estimates, Sales Lag

Lower selling prices and product mix as well as reduced volumes weigh on Quaker Chemical's (KWR) top line in Q1.

KWRPositive Net Change AVDPositive Net Change IOSPPositive Net Change ITRGPositive Net Change

Zacks Equity Research

Asbury (ABG) Stock Falls 1% Since Q1 Earnings & Sales Miss

Asbury's (ABG) first-quarter earnings miss estimates due to lower-than-expected gross profit from new vehicle, parts and service, and finance and insurance businesses.

GPIPositive Net Change SAHPositive Net Change ABGPositive Net Change LADNegative Net Change

Zacks Equity Research

Beam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss

Beam Therapeutics (BEAM) reports mixed first-quarter results. The company remains focused on pipeline development.

LGNDPositive Net Change BEAMNegative Net Change ENTXNegative Net Change THRDNegative Net Change

Zacks Equity Research

Penumbra (PEN) Q1 Earnings Lag Estimates, Margins Expand

Penumbra's (PEN) Thrombectomy product category shows encouraging growth trends, reflecting strong momentum in CAVT products.

RMDNegative Net Change PENNegative Net Change MEDPNegative Net Change EHCNegative Net Change

Zacks Equity Research

Disney (DIS) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

Disney's (DIS) second-quarter fiscal 2024 results reflect growth in Disney+ subscribers and theme park and resort businesses.

TTWONegative Net Change DISNegative Net Change SNNegative Net Change RBLXNegative Net Change

Zacks Equity Research

Sunoco (SUN) Beats on Q1 Earnings, Ups '24 Adjusted EBITDA View

Sunoco's (SUN) first-quarter earnings and revenues beat estimates on the back of increased revenues from the fuel distribution and marketing segment.

HESNegative Net Change VLOPositive Net Change SUNPositive Net Change EOGNegative Net Change

Zacks Equity Research

Halozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates

Halozyme (HALO) reports mixed first-quarter 2024 earnings. The company maintains revenue guidance for 2024.

RHHBYPositive Net Change JNJPositive Net Change HALOPositive Net Change LGNDPositive Net Change

Zacks Equity Research

Installed Building (IBP) to Report Q1 Earnings: What to Expect?

Installed Building's (IBP) first-quarter 2024 results are likely to reflect solid sales in multi-family residential and commercial end markets, along with the effective implementation of operational excellence.

ROCKNegative Net Change TREXNegative Net Change IBPNegative Net Change JBIPositive Net Change

Zacks Equity Research

Diamondback (FANG) Q1 Earnings Beat Estimates as Output Jumps

For 2024, Diamondback Energy (FANG) continues to maintain a capital spending budget between $2.30 billion and $2.55 billion and looks to pump around 458,000-466,000 BOE/d of hydrocarbon.

COPNegative Net Change MRONegative Net Change EQTNegative Net Change FANGNegative Net Change